New Approaches in Heart Research: Prevention Instead of Cardiomyoplasty?

Ralf Gaebel1,2, Cajetan Lang1,2, Praveen Vasudevan1,2

  • 1Department of Cardiac Surgery, Rostock University Medical Center, 18057 Rostock, Germany.

Insights

Lifestyle interventions like exercise and healthy nutrition significantly reduce cardiovascular disease risk, especially in obese individuals. Research is intensifying to understand mechanisms and tailor personalized prevention strategies.

Area of Science:

  • Cardiology and Exercise Physiology
  • Obesity and Cardiovascular Health

Background:

  • Cardiovascular diseases (CVDs) are a leading cause of death and significant healthcare cost in industrialized nations.
  • Obesity exacerbates CVD risk through hemodynamic load, inflammation, and impaired healing, contributing to conditions like myocardial infarction and heart failure.
  • While lifestyle interventions (exercise, nutrition, smoking cessation) are known to reduce CVD risk, underlying mechanisms and evidence quality lag behind pharmacological approaches.

Purpose of the Study:

  • To review the link between obesity, exercise, and cardiovascular disease.
  • To explore potential mechanisms by drawing lessons from stem-cell transplantation and preventive exercise.
  • To highlight the need for intensified research in personalized CVD prevention.

Main Methods:

  • Literature review focusing on the interplay of obesity, exercise, and cardiovascular health.
  • Exploration of insights from stem-cell transplantation research.
  • Application of advanced transcriptome analysis techniques.

Main Results:

  • Obesity significantly increases cardiovascular risk and negatively impacts healing processes.
  • Lifestyle interventions offer substantial preventive benefits for cardiovascular diseases.
  • State-of-the-art transcriptome analysis enables personalized risk factor targeting.

Conclusions:

  • Intensified research is crucial for advancing understanding and clinical application of preventive strategies for cardiovascular diseases.
  • Personalized interventions, informed by molecular insights, hold promise for managing obesity-related cardiovascular risks.
  • Integrating knowledge from exercise physiology and regenerative medicine can enhance CVD prevention.

Related Concept Videos

Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
19
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
12
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
17
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
25
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
471
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
16